Back to Search
Start Over
Air Pollution Particulate Matter Amplifies White Matter Vascular Pathology and Demyelination Caused by Hypoperfusion.
- Source :
-
Frontiers in immunology [Front Immunol] 2021 Nov 16; Vol. 12, pp. 785519. Date of Electronic Publication: 2021 Nov 16 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Cerebrovascular pathologies are commonly associated with dementia. Because air pollution increases arterial disease in humans and rodent models, we hypothesized that air pollution would also contribute to brain vascular dysfunction. We examined the effects of exposing mice to nanoparticulate matter (nPM; aerodynamic diameter ≤200 nm) from urban traffic and interactions with cerebral hypoperfusion. C57BL/6 mice were exposed to filtered air or nPM with and without bilateral carotid artery stenosis (BCAS) and analyzed by multiparametric MRI and histochemistry. Exposure to nPM alone did not alter regional cerebral blood flow (CBF) or blood brain barrier (BBB) integrity. However, nPM worsened the white matter hypoperfusion (decreased CBF on DSC-MRI) and exacerbated the BBB permeability (extravascular IgG deposits) resulting from BCAS. White matter MRI diffusion metrics were abnormal in mice subjected to cerebral hypoperfusion and worsened by combined nPM+BCAS. Axonal density was reduced equally in the BCAS cohorts regardless of nPM status, whereas nPM exposure caused demyelination in the white matter with or without cerebral hypoperfusion. In summary, air pollution nPM exacerbates cerebrovascular pathology and demyelination in the setting of cerebral hypoperfusion, suggesting that air pollution exposure can augment underlying cerebrovascular contributions to cognitive loss and dementia in susceptible elderly populations.<br />Competing Interests: WM is a consultant for Rebound Therapeutics, Viseon, Imperative Care, Integra, Q’Apel, Stryker, Stream Biomedical, Spartan Micro. WM is an investor for Cerebrotech, Endostream, Viseon, Rebound, Spartan Micro, Truvic, Imperative Care, Q’Apel. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Huuskonen, Liu, Lamorie-Foote, Shkirkova, Connor, Patel, Montagne, Baertsch, Sioutas, Morgan, Finch, Zlokovic and Mack.)
- Subjects :
- Animals
Blood-Brain Barrier drug effects
Blood-Brain Barrier pathology
Cerebrovascular Circulation drug effects
Cognitive Dysfunction etiology
Cognitive Dysfunction pathology
Demyelinating Diseases etiology
Demyelinating Diseases pathology
Disease Models, Animal
Humans
Male
Mice
Microglia drug effects
Microglia pathology
Severity of Illness Index
Vehicle Emissions
White Matter blood supply
White Matter drug effects
White Matter pathology
Air Pollutants adverse effects
Carotid Stenosis complications
Cognitive Dysfunction diagnosis
Demyelinating Diseases diagnosis
Particulate Matter adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 34868068
- Full Text :
- https://doi.org/10.3389/fimmu.2021.785519